Despite the current undervaluation of PTVE, the negative growth outlook introduces a level of uncertainty and risk. Potential investors are advised to research further into the stock and consider the risks associated with negative future growth prospects.
The pessimism of the analyst cohort reflected in Pactiv Evergreen's declining revenue forecasts might impact its stocks. The current high P/S may not be sustainable due to these decreasing revenues.
Although Pactiv Evergreen's dividends were covered by free cash flow, its lack of profitability last year is worrisome. Dividend investors need to see evidence of sustained profitability to be positive.
RDK79 :
Only noted more downgraded than upgrades, lot of analysts late to the party. And a bunch of new ‘initiated’ by mostly unknown folks, but also a few surprised weren’t previously covered, like DIS.
パクティブ・エバーグリーンに関するコメント
コラムToday's pre-market stock movers: CRM, WB, LI, NIO and more
• $ヴィクトリアズ・シークレット(VSCO.US)$ +10.4% (In reaction to earnings)
• $セールスフォース(CRM.US)$ +9.0% (In reaction to earnings)
• $ナビゲーター・ホールディングス(NVGS.US)$ +4.9% (names Mads Peter Zacho as CEO)
• $ウェイボー(WB.US)$ +4.7% (In reaction to earnings)
• $CAE(CAE.US)$ +4.7% (In reaction to earnings)
• $Laredo Petroleum(LPI.US)$ +4% (authorized $200 mln share repurchase program)
• $アクサム・セラピューティクス(AXSM.US)$ +3.1% (Late-Breaking Presentations of P...
コラムToday's pre-market stock movers: BNTX, JPM, RIVN, HPQ and more
• $ジェンコ・シッピング&トレーディング(GNK.US)$ +4.7% (positive Barrons article)
• $ネクストデケード(NEXT.US)$ +4.7% (files for 4618226 share common stock offering by selling shareholder)
• $コンパス・パスウェイズ(CMPS.US)$ +4.7% (COMPASS Pathways presents largest ever study of psilocybin therapy at American Psychiatric Association annual meeting)
• $カヌー(GOEV.US)$ +3.5% (files for 48043111 share common stock offering by selling shareholder)
• $アメリカン・アクスル&マニュファクチャリング・ホールテ(AXL.US)$ +3.7% (pr...
コラムTop upgrades and downgrades on 5/23
• $キューブスマート(CUBE.US)$ : Raymond James Upgrades to Strong Buy from Outperform - PT $52 (from $60)
• $DTEエナジー(DTE.US)$ : Credit Suisse Upgrades to Outperform from Neutral - PT $140 (from $142)
• $コンソリデーテッド・エジソン(ED.US)$ : Guggenheim Upgrades to Neutral from Sell - PT $94 (from $80)
• $モトローラ ソリューションズ(MSI.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $240
• $グルポ・エアロポルチュアリオ・デル・セントロ・ノルテ(OMAB.US)$ : Morgan Stanley Upgrades to...
コラムTop upgrades and downgrades on 5/6
• $ブート・バーン・ホールディングス(BOOT.US)$ : Piper Sandler Upgrades to Overweight from Neutral - PT $121 (from $109)
• $EPAMシステムズ(EPAM.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $400 (from $312)
• $Hersha Hospitality Trust(HT.US)$ : Stifel Upgrades to Buy from Hold - PT $14.50 (from $11)
• $Jounce Therapeutics(JNCE.US)$ : Raymond James Upgrades to Strong Buy from Outperform - PT $20 (from $15)
• $パクティブ・エバーグリーン(PTVE.US)$ : RBC Capital Upgra...
コラムTop upgrades and downgrades on 4/14
• $CDW(CDW.US)$: Stifel Upgrades to Buy from Hold - PT $210 (from $200)
• $コルテバ(CTVA.US)$ : Loop Capital Upgrades to Buy from Hold - PT $69
• $コレクションズ・コーポレーション・オブ・アメリカ(CXW.US)$ : Wedbush Upgrades to Outperform from Neutral - PT $17 (from $10.85)
• $デルタ航空(DAL.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $60 (from $42)
• $H.B.フラー(FUL.US)$ : Baird Upgrades to Outperform from Neutral - PT $85
• $ハンティントン・インガルス・インダストリーズ(HII.US)$ : Cowen U...
the float still so much left?
まだコメントはありません